ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Dietary Macronutrients and Weight Loss

This study is not yet open for patient recruitment.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)

Purpose

To test the effectiveness for weight loss and weight maintenance of four diets differing in macronutrient composition: moderate in fat (35 percent energy) with two different protein levels (15 percent and 25 percent), and low in fat (20 percent energy), also with 15 percent and 25 percent protein.

Condition
Cardiovascular Diseases
Heart Diseases
Obesity

MedlinePlus related topics:  Circulatory Disorders;   Heart Diseases;   Heart Diseases--Prevention;   Obesity

Study Type: Observational
Study Design: Natural History

Further Study Details: 

Study start: September 2003;  Study completion: July 2007

BACKGROUND: Obesity is a growing problem whose importance is reflected in the resources that are expended each year by a large section of the population on weight reduction drugs and therapies. Although numerous weight loss diets are available, there is little agreement in the scientific literature or the lay press as to the amount of fat, protein and carbohydrates that would comprise the most efficacious diet for weight loss and long term weight loss retention. Reliable information about the effectiveness of low calorie diets with low fat/moderate protein, low fat/high protein, moderate fat/moderate protein and moderate fat/high protein to be examined in this study is clearly needed and of paramount importance to the informed choice of a weight reduction diet.

DESIGN NARRATIVE: The study tests the effectiveness for weight loss and weight maintenance of four diets differing in macronutrient composition: moderate in fat (35% energy) with two different protein levels (15% and 25%), and low in fat (20% energy), also with 15% and 25% protein. The moderate-fat diet will be patterned after a Mediterranean diet. All four dietary approaches will be low in saturated fat, and will involve reduction in total energy intake. All participants will receive a state-of-the-art behavioral therapy program standardized across the two centers in Boston and Baton Rouge. The investigators will test the hypothesis that higher baseline insulin, respiratory quotient (RQ) and VO2max will be associated with smaller weight loss and more difficulty maintaining the weight loss during maintenance. Dietary satisfaction and satiety will be assessed as potential predictors of success. An estimated 400 men and 400 women, BMI 27-39 kg/m2, will be randomized among the 4 dietary treatments. Each diet will be developed to be practical and suitable for public health recommendations, and would be expected to have a favorable effect on cardiovascular risk factors. The primary outcome variable will be change in total body weight from baseline to 2 years. Secondary outcomes related to obesity are total body fat, visceral fat mass, BMI, and waist and hip circumferences. Other outcomes include blood pressure, fasting blood lipids, apolipoproteins, insulin, glucose, and hemoglobin A1C.

Eligibility

Ages Eligible for Study:  20 Years   -   65 Years,  Genders Eligible for Study:  Both

Criteria

No eligibility criteria

Location Information


Study chairs or principal investigators

Frank Sacks,  Harvard University School of Public Health   

More Information

Study ID Numbers:  1238
Record last reviewed:  August 2004
Record first received:  November 13, 2003
ClinicalTrials.gov Identifier:  NCT00072995
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-10-29
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act